期刊文献+

布南色林分散片的处方研究 被引量:5

Study on the Formula of Blonanserin Dispersible Tablets
原文传递
导出
摘要 目的:采用正交试验筛选布南色林分散片的处方。方法:以内崩解剂微晶纤维素的用量、填充剂乳糖的用量、外崩解剂羧甲基淀粉钠的用量、黏合剂羟丙基甲基纤维素溶液的浓度为考查因素,以分散片的崩解时间、脆碎度和分散均匀性为评价指标进行正交试验,确定最佳处方;并对优化的处方进行工艺验证及质量评价。结果:优选处方为含微晶纤维素30%、乳糖50%、羧甲基淀粉钠0.5%,羟丙基甲基纤维素溶液浓度为2%;所制样品平均崩解时间为10.8s,脆碎度为0.29%,分散均匀性合格,30min药物累积溶出百分率超过75%。结论:布南色林分散片处方设计较为合理。 OBJECTIVE: To optimize the formula of Blonanserin dispersible tablets by orthogonal experiment. METHODS: The formula of tablets was optimized by orthogonal experiment using the amount of microcrystalline cellulose, lactose, sodium carboxymethyl starch and the concentration of hydroxypropyl methyl cellulose as factors and with disintegrating time, friability and the dispersibility homogenization as indices. The optimized preparation technology was verified, the quality of tablets was evaluated. RESULTS: The optimal formula was as follows: the proportions of microcrystalline cellulose, lactose, the sodium carboxymethyl starch and concentration of hydroxypropyl methyl cellulose were 30%, 50%, 0.5% and 2% respectively. The average disintegrating time was 10.8 s and friability was 0.29%, it was good in dispersibility homogenization. The accumulative dissolution rate was over 75% within 30 min. CONCLUSION: The formula of Blonanserin dispersible tablets is reasonable.
出处 《中国药房》 CAS CSCD 北大核心 2011年第13期1193-1196,共4页 China Pharmacy
关键词 布南色林 分散片 正交试验法 处方研究 质量评价 Blonanserin Dispersible tablets Orthogonal experiment Formula study Quality evaluation
  • 相关文献

参考文献3

二级参考文献34

  • 1王卓,韩丽梅,张晓青,邓英杰,张艳华,王越.利用均匀设计筛选阿司匹林分散片处方[J].沈阳药科大学学报,1996,13(4):235-239. 被引量:18
  • 2李莉,陈冠容.不同厂家阿莫西林口服制剂溶出度比较[J].中国医院药学杂志,1997,17(1):29-30. 被引量:2
  • 3Oka M, Noda Y, Ochi Y, et al. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties [J]. J PharmacolExp Ther, 1993, 264(1) : 158-176.
  • 4Oka M, Hino K. AD-5423 [J]. Drugs Future, 1992, 17(1): 9-11.
  • 5Katsuhiko H, Naoki K, Masato S, et al. 2-(1-Piperazinyl)- 4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same: EP, 385237 [P]. 1990-09-05. (CA 1990, 114: 143438)
  • 6Alonso-alij C, Michels M, Schirok H, et al. Monocyclic aroylpyridinones as antiinflammatory agents: WO, 200376405 [P]. 2003-09-18. (CA 2003, 139: 261170)
  • 7Hauser CR, Eby CJ. Cyclization of β-ketonitriles or β-ketoamides with ketones by polyphosphoric acid to form substituted 2-pyfidones [J]. J Am Chem Soc, 1957, 79 (3) : 728-731.
  • 8黄胜炎.分散片进展,1992(04).
  • 9Dominique L. S. Ceulemans,Yves G. Gelders,Marie-Lise J. A. Hoppenbrouwers,André J. M. Reyntjens,Paul A. J. Janssen. Effect of serotonin antagonism in schizophrenia: A pilot study with setoperone[J] 1985,Psychopharmacology(3):329~332
  • 10王晓洁,朱忠华.抗精神分裂症药布南色林的合成[J].科教文汇,2007(12Z):219-219. 被引量:12

共引文献42

同被引文献39

  • 1彭礼明.分散片处方、工艺特点及其进展[J].药品评价,2005,2(3):230-233. 被引量:27
  • 2Falkai P,Wobrock T,Lieberman J,et al.World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for biological treatment of schizophrenia,Part 1:acute treatment of schizophrenia[J].The World Journal of Biological Psychiatry,2005,6(3):132-191.
  • 3Schultz S.K,Andreasen N.C.Schizophrenia[J].ancet,1999,353:1425-1430.
  • 4Saha S,Chant D,Welham J,et al.A systematic review of the prevalence of schizophrenia[J].PLoS medicine,2005,2(5):413.
  • 5Auquier P,Lanon C,Rouillon F,et al.Mortality in schizophrenia[J].Pharmacoepidemiology and drug safety,2006,15(12):873-879.
  • 6Warner R,Girolamo D,成义仁,王克勤(译).精神分裂症[M].世界卫生组织,人民卫生出版社(1997).
  • 7梁冉,冯玉玲,孙京国.布南色林微米在药物的制备[C].中国化学会全国第十一届有机合成化学学术研讨会论文集,2014%.
  • 8Tenjin T,Miyamoto S,Ninomiya Y,et al.Profile of blonanserin for the treatment of schizophrenia[J].Neuropsychiatric disease and treatment,2013,9:587-594.
  • 9Miyamoto S,Duncan G E,Marx C E,et al.Treatments for schizophrenia:a critical review of pharmacology and mechanisms of action of antipsychotic drugs[J].Molecular psychiatry,2005,10(1):79-104.
  • 10Kishi T,Matsuda Y,Nakamura H,et al.Blonanserin for schizophrenia:systematic review and meta-analysis of double-blind,randomized,controlled trials[J].Journal of psychiatric research,2013,47(2):149-154.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部